Acinetobacter baumannii is dependent on the type II secretion system and its substrate LipA for lipid utilization and in vivo fitness

Journal of Bacteriology

Volumn 198, Issue 4, 2016, Pages 711-719

  Johnson, Tanya L ^a,b   Waack, Ursula ^a   Smith, Sara ^a   Mobley, Harry ^a   Sandkvist, Maria ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b EASTERN MICHIGAN UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CARBON; GSPD PROTEIN; GSPE PROTEIN; LIPA PROTEIN; LIPID; LONG CHAIN FATTY ACID; TETRAHYDROLIPSTATIN; TRIACYLGLYCEROL LIPASE; UNCLASSIFIED DRUG; VIRULENCE FACTOR; BACTERIAL PROTEIN; LIPA PROTEIN, BACTERIA; TYPE II SECRETION SYSTEM;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTION; ANIMAL MODEL; ARTICLE; BACTEREMIA; BACTERIAL COLONIZATION; BACTERIAL GENE; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIUM MUTANT; BROTH DILUTION; CARBON SOURCE; CONTROLLED STUDY; ENZYME SUBSTRATE; FEMALE; FITNESS; GENE DELETION; GENETIC ORGANIZATION; IN VITRO STUDY; IN VIVO STUDY; INOCULATION; LIVER; MOUSE; NEUTROPENIA; NONHUMAN; NUTRIENT; OPERON; PRIORITY JOURNAL; SPLEEN; TYPE II SECRETION SYSTEM; WILD TYPE; AMINO ACID SEQUENCE; ANIMAL; CBA MOUSE; CHEMISTRY; ENZYMOLOGY; GENETICS; HUMAN; LIPID METABOLISM; METABOLISM; MICROBIOLOGY; MOLECULAR GENETICS; SEQUENCE ALIGNMENT;

ACINETOBACTER BAUMANNII; ACINETOBACTER INFECTIONS; AMINO ACID SEQUENCE; ANIMALS; BACTERIAL PROTEINS; FEMALE; HUMANS; LIPID METABOLISM; MICE, INBRED CBA; MOLECULAR SEQUENCE DATA; SEQUENCE ALIGNMENT; TYPE II SECRETION SYSTEMS;

EID: 84958093657     PISSN: 00219193     EISSN: 10985530     Source Type: Journal    
DOI: 10.1128/JB.00622-15     Document Type: Article

References (85)

1. Mak JK, Kim M-J, Pham J, Tapsall J, White PA. 2009. Antibiotic resistance determinants in nosocomial strains of multidrug-resistant Acinetobacter baumannii. J Antimicrob Chemother 63:47-54.
2. Peleg AY, Seifert H, Paterson DL. 2008. Acinetobacter baumannii: emergence of a successful pathogen. Clin Microbiol Rev 21:538-582. http://dx.doi.org/10.1128/CMR.00058-07.
3. Qi C, Malczynski M, Parker M, Scheetz MH. 2008. Characterization of genetic diversity of carbapenem-resistant Acinetobacter baumannii clinical strains collected from 2004 to 2007. J Clin Microbiol 46:1106-1109. http://dx.doi.org/10.1128/JCM.01877-07.
4. Bergogne-Bérézin E, Towner KJ. 1996. Acinetobacter spp. as nosocomial pathogens: microbiological, clinical and epidemiological features. Clin Microbiol Rev 9:148-165.
5. Beck-Sagué CM, Jarvis WR, Brook JH, Culber DH, Potts A, Gay E, Shotts BW, Hill B, Anderson RL, Weinstein MP. 1990. Epidemic bacteremia due to Acinetobacter baumannii in five intensive care units. Am J Epidemiol 132:723-733.
6. Playford EG, Craig JC, Iredell JR. 2007. Carbapenem-resistant Acinetobacter baumannii in intensive care unit patients: risk factors for acquisition, infection and their consequences. J Hosp Infect 65:204-211. http://dx.doi.org/10.1016/j.jhin.2006.11.010.
7. Maragakis LL, Perl TM. 2008. Acinetobacter baumannii: epidemiology, antimicrobial resistance, and treatment options. Clin Infect Dis 46:1254-1263. http://dx.doi.org/10.1086/529198.
8. Garnacho-Montero J, Ortiz-Leyba C, Jimenez-Jimenez F, Barrero-Almodovar A, Garcia-Garmendia J, Bernabeu-Wittell M, Gallego-Lara S, Madrazo-Osuna J. 2003. Treatment of multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia (VAP) with intravenous colistin: a comparison with imipenem-susceptible VAP. Clin Infect Dis 36:1111-1118. http://dx.doi.org/10.1086/374337.
9. Falagas ME, Rafailidis PI, Kasiakou S, Hatzopoulou KP, Michalopoulos A. 2006. Effectiveness and nephrotoxicity of colistin monotherapy vs. colistin-meropenem combination therapy for multidrug-resistant Gramnegative bacterial infections. Clin Microb Infect 12:1227-1230. http://dx.doi.org/10.1111/j.1469-0691.2006.01559.x.
10. Espinal P, Marti S, Vila J. 2012. Effect of biofilm formation on the survival of Acinetobacter baumannii on dry surfaces. J Hosp Infect 80:56-60. http://dx.doi.org/10.1016/j.jhin.2011.08.013.
11. Wendt C, Dietze B, Dietz E, Ruden H. 1997. Survival of Acinetobacter baumannii on dry surfaces. J Clin Microbiol 35:1394-1397.
12. Weernink A, Severin WPJ, Tjernberg I, Dijkshoorn L. 1995. Pillows, an unexpected source of Acinetobacter. J Hosp Infect 29:189-199. http://dx.doi.org/10.1016/0195-6701(95)90328-3.
13. Russo T, Luke NR, Beanan JM, Olson R, Sauberan SL, MacDonald U, Schultz LW, Umland TC, Campagnari AA. 2010. The K1 capsular polysaccharide of Acinetobacter baumannii strain 307-0294 is a major virulence factor. Infect Immun 78:3993-4000. http://dx.doi.org/10.1128/IAI.00366-10.
14. Hall-Stoodley L, Stoodley P. 2009. Evolving concepts in biofilm infections. Cell Microbiol 11:1034-1043. http://dx.doi.org/10.1111/j.1462-5822.2009.01323.x.
15. Mah T-F. 2012. Biofilm-specific antibiotic resistance. Future Microbiol 7:1061-1072. http://dx.doi.org/10.2217/fmb.12.76.
16. Madsen JS, Burmolle M, Hansen LH, Sorenson SJ. 2012. The interconnection between biofilm formation and horizontal gene transfer. FEMS Immunol Med Microbiol 65:183-195. http://dx.doi.org/10.1111/j.1574-695X.2012.00960.x.
17. Jawad A, Seifert H, Snelling AM, Heritage J, Hawkey PM. 1998. Survival of Acinetobacter baumannii on dry surfaces: comparison of outbreak and sporadic isolates. J Clin Microbiol 36:1938-1941.
18. Tomaras AP, Dorsey CW, Edelmann R, Actis LA. 2003. Attachment to and biofilm formation on abiotic surfaces by Acinetobacter baumannii: involvement of a novel chaperone-usher pili assembly system. Microbiology 149:3473-3484. http://dx.doi.org/10.1099/mic.0.26541-0.
19. Gaddy JA, Tomaras AP, Actis LA. 2009. The Acinetobacter baumannii 19606 OmpA protein plays a role in biofilm formation on abiotic surfaces and in the interaction of this pathogen with eukaryotic cells. Infect Immun 77:3150-3160. http://dx.doi.org/10.1128/IAI.00096-09.
20. Choi AHK, Slamti L, Avci FY, Pier GB, Maira-Litran T. 2009. The pgaABCD locus of Acinetobacter baumannii encodes the production of poly-beta-1-6-N-acetylglucosamine, which is critical for biofilm formation. J Bacteriol 191:5953-5963. http://dx.doi.org/10.1128/JB.00647-09.
21. Harding CM, Tracy EN, Carruthers MD, Rather PN, Actis LA, Munson RSJ. 2013. Acinetobacter baumannii strain M2 produces type IV pili which play a role in natural transformation and twitching motility but not surface-associated motility. mBio 4:e00360-13. http://dx.doi.org/10.1128/mBio.00360-13.
22. Carruthers MD, Nicholson PA, Tracy EN, Munson RSJ. 2013. Acinetobacter baumannii utilizes a type VI secretion system for bacterial competition. PLoS One 8:e59388. http://dx.doi.org/10.1371/journal.pone.0059388.
23. Smith MG, Gianoulis TA, Pukatzki S, Mekalanos JJ, Ornston LN, Gerstein M, Snyder M. 2007. New insights into Acinetobacter baumannii pathogenesis revealed by high-density pyrosequencing and transposon mutagenesis. Genes Dev 21:601-614. http://dx.doi.org/10.1101/gad.1510307.
24. Tseng T-T, Tyler BM, Setubal JC. 2009. Protein secretion systems in bacterial-host associations, and their description in the Gene Ontology. BMC Microbiol 9(Suppl 1):S2. http://dx.doi.org/10.1186/1471-2180-9-S1-S2.
25. Eijkelkamp BA, Stroeher UH, Hassan KA, Paulsen IT, Brown MH. 2014. Comparative analysis of surface-exposed virulence factors of Acinetobacter baumannii. BMC Genomics 15:1020-1031. http://dx.doi.org/10.1186/1471-2164-15-1020.
26. Cianciotto NP. 2005. Type II secretion: a protein secretion system for all seasons. Trends Microbiol 13:581-588. http://dx.doi.org/10.1016/j.tim.2005.09.005.
27. Sandkvist M. 2001. Type II secretion and pathogenesis. Infect Immun 69:3523-3535. http://dx.doi.org/10.1128/IAI.69.6.3523-3535.2001.
28. Filloux A. 2011. Protein secretion systems in Pseudomonas aeruginosa: an essay on diversity, evolution, and function. Front Microbiol 2:155-175.
29. Rondelet A, Condemine G. 2013. Type II secretion: the substrates that won't go away. Res Microbiol 164:556-561. http://dx.doi.org/10.1016/j.resmic.2013.03.005.
30. Sikora AE, Zielke RA, Lawrence DA, Andrews PC, Sandkvist M. 2011. Proteomic analysis of the Vibrio cholerae type II secretome reveals new proteins, including three related serine proteases. J Biol Chem 286:16555-16566. http://dx.doi.org/10.1074/jbc. M110.211078.
31. Sikora AE, Lybarger SR, Sandkvist M. 2007. Compromised outer membrane integrity in Vibrio cholerae type II secretion mutants. J Bacteriol 189:8484-8495. http://dx.doi.org/10.1128/JB.00583-07.
32. Iwobi A, Heesemann J, Garcia E, Igwe E, Noelting C, Rakin A. 2003. Novel virulence-associated type II secretion system unique to highpathogenicity Yersinia enterocolitica. Infect Immun 71:1872-1879. http://dx.doi.org/10.1128/IAI.71.4.1872-1879.2003.
33. Ho TD, Davis BM, Ritchie JM, Waldor MK. 2008. Type 2 secretion promotes enterohemorrhagic Escherichia coli adherence and intestinal colonization. Infect Immun 76:1858-1865. http://dx.doi.org/10.1128/IAI.01688-07.
34. Jyot J, Balloy V, Jouvion G, Verma A, Touqui L, Huerre M, Chignard M, Ramphal R. 2011. Type II secretion system of Pseudomonas aeruginosa: in vivo evidence of a significant role in death due to lung infection. J Infect Dis 203:1369-1377. http://dx.doi.org/10.1093/infdis/jir045.
35. McCoy-Simandle K, Stewart CR, Dao J, DebRoy S, Rossier O, Bryce PJ, Cianciotto NP. 2011. Legionella pneumophila type II secretion dampens the cytokine response of infected macrophages and epithelia. Infect Immun 79:1984-1997. http://dx.doi.org/10.1128/IAI.01077-10.
36. Baldi DL, Higginson EE, Hocking DM, Praszkier J, Cavaliere R, James CE, Bennett-Wood V, Azzopardi KI, Turnbull L, Lithgow T, Robins-Browne RM, Whitchurch CB, Tauschek M. 2012. The type II secretion system and its ubiquitous lipoprotein substrate, SslE, are required for biofilm formation and virulence of enteropathogenic Escherichia coli. Infect Immun 80:2042-2052. http://dx.doi.org/10.1128/IAI.06160-11.
37. Sandkvist M, Morales V, Bagdasarian M. 1993. A protein required for secretion of cholera toxin through the outer membrane of Vibrio cholerae. Gene 123:81-86. http://dx.doi.org/10.1016/0378-1119(93)90543-C.
38. Tauschek M, Gorrell RJ, Strugnell RA, Robins-Browne RM. 2002. Identification of a protein secretory pathway for the secretion of heatlabile enterotoxin by an enterotoxigenic strain of Escherichia coli. Proc Natl Acad Sci U S A 99:7066-7071. http://dx.doi.org/10.1073/pnas.092152899.
39. DebRoy S, Dao J, Soderberg M, Rossier O, Cianciotto NP. 2006. Legionella pneumophila type II secretome reveals unique exoproteins and a chitinase that promotes bacterial persistence in the lung. Proc Natl Acad Sci U S A 103:19146-19151. http://dx.doi.org/10.1073/pnas.0608279103.
40. Korotkov KV, Sandkvist M, Hol WGJ. 2012. The type II secretion system: biogenesis, molecular architecture and mechanism. Nat Rev Microbiol 10:336-351.
41. Douzi B, Filloux A, Voulhoux R. 2012. On the path to uncover the bacterial type II secretion system. Philos Trans R Soc Lond B Biol Sci 367:1059-1072. http://dx.doi.org/10.1098/rstb.2011.0204.
42. Nivaskumar M, Francetic O. 2014. Type II secretion system: a magic beanstalk or a protein escalator. Biochim Biophys Acta 1843:1568-1577. http://dx.doi.org/10.1016/j.bbamcr.2013.12.020.
43. Morales VM, Backman A, Bagdasarian M. 1991. A series of wide-host-range low-copy-number vectors that allow for direct screening for recombinants. Gene 97:39-47. http://dx.doi.org/10.1016/0378-1119(91)90007-X.
44. Kagami Y, RatliffM, Surber M, Martinez A, Nunn DN. 1998. Type II protein secretion by Pseudomonas aeruginosa: genetic suppression of a conditional mutation in the pilin-like component XcpT by the cytoplasmic component XcpR. Mol Microbiol 27:221-233.
45. Kok RG, van Thor JJ, Nugteren-Roodzant IM, Brouwer MBW, Egmond MR, Nudel CB, Vosman B, Hellingwerf KJ. 1995. Characterization of the extracellular lipase, LipA, of Acinetobacter calcoaceticus BD413 and sequence analysis of the cloned structural gene. Mol Microbiol 15:803-818. http://dx.doi.org/10.1111/j.1365-2958.1995.tb02351.x.
46. Ogierman MA, Fallarino A, Riess T, Williams SG, Attridge SR, Manning PA. 1997. Characterization of the Vibrio cholerae El Tor lipase operon lipAB and a protease gene downstream of the hly region. J Bacteriol 179:7072-7080.
47. Sullivan ER, Leahy JG, Colwell RR. 1999. Cloning and sequence analysis of the lipase and lipase chaperone-encoding genes from Acinetobacter calcoaceticus RAG-1, and redefinition of a Proteobacterial lipase family and an analogous lipase chaperone family. Gene 230:277-285. http://dx.doi.org/10.1016/S0378-1119(99)00026-8.
48. Frenken LGJ, Bos JW, Visser C, Muller W, Tommassen J, Verrips CT. 1993. An accessory gene, lipB, required for the production of active Pseudomonas glumae lipase. Mol Microbiol 9:579-589. http://dx.doi.org/10.1111/j.1365-2958.1993.tb01718.x.
49. Frenken LGJ, de Groot A, Tommassen J, Verrips CT. 1993. Role of the lipB gene product in the folding of the secreted lipase of Pseudomonas glumae. Mol Microbiol 9:591-599. http://dx.doi.org/10.1111/j.1365-2958.1993.tb01719.x.
50. Jaeger K-E, Ransac S, Dijkstra BW, Colson C, van Heuvel M, Misset O. 1994. Bacterial lipases. FEMS Microbiol Rev 15:29-63. http://dx.doi.org/10.1111/j.1574-6976.1994.tb00121.x.
51. Snellman EA, Colwell RR. 2004. Acinetobacter lipases: molecular biology, biochemical properties and biotechnological potential. J Ind Microbiol Biotechnol 31:391-400. http://dx.doi.org/10.1007/s10295-004-0167-0.
52. Heck AM, Yanovski JA, Calis KA. 2000. Orlistat, a new lipase inhibitor for the management of obesity. Pharmacotherapy 20:270-279. http://dx.doi.org/10.1592/phco.20.4.270.34882.
53. Weibel EK, Hadvary P, Hochuli E, Kupfer E, Lengsfeld H. 1987. Lipstatin, an inhibitor of pancreatic lipase, produced by Streptomyces toxytricini. I. Producing organism, fermentation, isolation and biological activity. J Antibiot (Tokyo) 40:1081-1085.
54. Subashchandrabose S, Smith SN, Spurbeck RR, Kole MM, Mobley HLT. 2013. Genome-wide detection of fitness genes in uropathogenic Escherichia coli during systemic infection. PLoS Pathog 9:e1003788. http://dx.doi.org/10.1371/journal.ppat.1003788.
55. Eveillard M, Soltner C, Kempf M, Saint-Andre J-P, Lemarie C, Randrianarivelo C, Seifert H, WolffM, Joly-Guillou M-L. 2010. The virulence variability of different Acinetobacter baumannii strains in experimental pneumonia. J Infect 60:154-161. http://dx.doi.org/10.1016/j.jinf.2009.09.004.
56. Subashchandrabose S, Smith S, DeOrnellas V, Crepin S, Kole M, Zahdeh C, Mobley HLT. 2015. Acinetobacter baumannii genes required for bacterial survival during bloodstream infection. mSphere 1:00013-15.
57. Possot OM, Vignon G, Bomchil N, Ebel F, Pugsley AP. 2000. Multiple interactions between pullulanase secreton components involved in stabilization and cytoplasmic membrane association of PulE. J Bacteriol 182: 2142-2152. http://dx.doi.org/10.1128/JB.182.8.2142-2152.2000.
58. Korotkov KV, Johnson TL, Jobling MG, Pruneda J, Pardon E, Héroux A, Turley S, Steyaert J, Holmes RK, Sandkvist M, Hol WGJ. 2011. Structural and functional studies on the interaction of GspC and GspD in the type II secretion system. PLoS Pathog 7:e1002228. http://dx.doi.org/10.1371/journal.ppat.1002228.
59. Korotkov KV, Krumm B, Bagdasarian M, Hol WGJ. 2006. Structural and functional studies of EpsC, a crucial component of the type 2 secretion system from Vibrio cholerae. J Mol Biol 363:311-321. http://dx.doi.org/10.1016/j.jmb.2006.08.037.
60. Lee H-M, Wang K-C, Liu Y-L, Yew H-Y, Chen L-Y, Leu W-M, Chen DC, Hu N-T. 2000. Association of the cytoplasmic membrane protein XpsN with the outer membrane protein XpsD in the type II protein secretion apparatus of Xanthomonas campestris pv. campestris. J Bacteriol 182: 1549-1557. http://dx.doi.org/10.1128/JB.182.6.1549-1557.2000.
61. Sandkvist M, Hough LP, Bagdasarian MM, Bagdasarian M. 1999. Direct interaction of the EpsL and EpsM proteins of the general secretion apparatus in Vibrio cholerae. J Bacteriol 181:3129-3135.
62. Korotkov KV, Hol WGJ. 2008. Structure of the GspK-GspI-GspJ complex from the enterotoxigenic Escherichia coli type 2 secretion system. Nat Struct Mol Biol 15:462-468. http://dx.doi.org/10.1038/nsmb.1426.
63. Sandkvist M, Bagdasarian M, Howard SP, DiRita VJ. 1995. Interaction between the autokinase EpsE and EpsL in the cytoplasmic membrane is required for extracellular secretion in Vibrio cholerae. EMBO J 14:1664-1673.
64. Abendroth J, Murphy P, Sandkvist M, Bagdasarian M, Hol WGJ. 2005. The X-ray structure of the type II secretion system complex formed by the N-terminal domain of EpsE and the cytoplasmic domain of EpsL of Vibrio cholerae. J Mol Biol 348:845-855. http://dx.doi.org/10.1016/j.jmb.2005.02.061.
65. Houten SM, Wanders RJA. 2010. A general introduction to the biochemistry of mitochondrial fatty acid β-oxidation. J Inherit Metab Dis 33:469-477. http://dx.doi.org/10.1007/s10545-010-9061-2.
66. Marques CNH, Morozov A, Planzos P, Zelaya HM. 2014. The fatty acid signaling molecule cis-2-decenoic acid increases metabolic activity and reverts persister cells to an antimicrobial-susceptible state. Appl Environ Microbiol 80:6976-6991.
67. Ryan RP, McCarthy Y, Watt SA, Niehaus K, Dow JM. 2009. Intraspecies signaling involving the diffusible signal factor BDSF (cis-2-dodecenoic acid) influences virulence in Burkholderia cenocepacia. J Bacteriol 191: 5013-5019. http://dx.doi.org/10.1128/JB.00473-09.
68. Kang Y, Nguyen DT, Son MS, Hoang TT. 2008. The Pseudomonas aeruginosa PsrA responds to long-chain fatty acid signals to regulate the fadBA5 b-oxidation operon. Microbiology 154:1584-1598. http://dx.doi.org/10.1099/mic.0.2008/018135-0.
69. Funken H, Knapp A, Vasil ML, Wilhelm S, Jaeger K-E, Rosenau F. 2011. The lipase LipA (PA2862) but not LipC (PA4813) from Pseudomonas aeruginosa influences regulation of pyoverdine production and expression of the sigma factor PvdS. J Bacteriol 193:5858-5860. http://dx.doi.org/10.1128/JB.05765-11.
70. Rosenau F, Isenhardt S, Gdynia A, Tielker D, Schmidt E, Tielen P, Schobert M, Jahn D, Wilhelm S, Jaeger K-E. 2010. Lipase LipC affects motility, biofilm formation and rhamnolipid production in Pseudomonas aeruginosa. FEMS Microbiol Lett 309:25-34.
71. Tielen P, Kuhn H, Rosenau F, Jaeger K-E, Flemming H-C, Wingender J. 2013. Interaction between extracellular lipase LipA and the polysaccharide alginate of Pseudomonas aeruginosa. BMC Microbiol 13:159-171. http://dx.doi.org/10.1186/1471-2180-13-159.
72. Pride AC, Herrera CM, Guan Z, Giles DK, Trent MS. 2013. The outer surface lipoprotein VolA mediates utilization of exogenous lipids by Vibrio cholerae. mBio 4:e00305-13. http://dx.doi.org/10.1128/mBio.00305-13.
73. Liu M, Zhu H, Li J, Garcia CC, Feng W, Kirpotina LN, Hilmer J, Tavares LP, Layton AW, Quinn MT, Bothner B, Teixeira MM, Lei B. 2012. Group A Streptococcus secreted esterase hydrolyzes plateletactivating factor to impede neutrophil recruitment and facilitate innate immune evasion. PLoS Pathog 8:e1002624. http://dx.doi.org/10.1371/journal.ppat.1002624.
74. Fu Y, Ibrahim AS, Fonzi W, Zhou X, Ramos CF, Ghannoum MA. 1997. Cloning and characterization of a gene (LIP1) which encodes a lipase from the pathogenic yeast Candida albicans. Microbiology 143:331-340. http://dx.doi.org/10.1099/00221287-143-2-331.
75. Park M, Do E, Jung WH. 2013. Lipolytic enzymes involved in the virulence of human pathogenic fungi. Mycobiology 41:67-72. http://dx.doi.org/10.5941/MYCO.2013.41.2.67.
76. Burtnick MN, Brett PJ, DeShazer D. 2014. Proteomic analysis of the Burkholderia pseudomallei type II secretome reveals hydrolytic enzymes, novel proteins, and the deubiquitinase TssM. Infect Immun 82:3214-3226. http://dx.doi.org/10.1128/IAI.01739-14.
77. Schäfer A, Tauch A, Jäger W, Kalinowski J, Thierbach G, Pühler A. 1994. Small mobilizable multi-purpose cloning vectors derived from the Escherichia coli plasmids pK18 and pK19: selection of defined deletions in the chromosome of Corynebacterium glutamicum. Gene 145:69-73. http://dx.doi.org/10.1016/0378-1119(94)90324-7.
78. Donnenberg MS, Kaper JB. 1991. Construction of an eae deletion mutant of enteropathogenic Escherichia coli by using positive-selection suicide vector. Infect Immun 59:4310-4317.
79. Fürste JP, Pansegrau W, Frank R, Blöcker H, Scholz P, Bagdasarian M, Lanka E. 1986. Molecular cloning of the plasmid RP4 primase region in a multi-host-range tacP expression vector. Gene 48:119-131. http://dx.doi.org/10.1016/0378-1119(86)90358-6.
80. Casadaban MJ, Cohen SN. 1980. Analysis of gene control signals by DNA fusion and cloning in Escherichia coli. J Mol Biol 138:179-207. http://dx.doi.org/10.1016/0022-2836(80)90283-1.
81. Figurski DH, Helinski DR. 1979. Replication of an origin-containing derivative of plasmid RK2 dependent on a plasmid function provided in trans. Proc Natl Acad Sci U S A 76:1648-1652. http://dx.doi.org/10.1073/pnas.76.4.1648.
82. Miller G, Feiss M. 1988. The bacteriophage λ cohesive end site: isolation of spacing/substitution mutations that result in dependence on Escherichia coli integration host factor. Mol Gen Genet 212:157-165. http://dx.doi.org/10.1007/BF00322459.
83. Vallenet D, Nordmann P, Barbe V, Poirel L, Mangenot S, Bataille E, Dossat C, Gas S, Kreimeyer A, Lenoble P, Oztas S, Poulain J, Segurens B, Robert C, Abergel C, Claverie J-M, Raoult D, Médigue C, Weissenbach J, Cruveiller S. 2008. Comparative analysis of acinetobacters: three genomes for three lifestyles. PLoS One 3:e1805. http://dx.doi.org/10.1371/journal.pone.0001805.
84. Adams MD, Goglin K, Molyneaux N, Hujer KM, Lavender H, Jamison JJ, MacDonald IJ, Martin KM, Russo T, Campagnari AA, Hujer AM, Bonomo RA, Gill SR. 2008. Comparative genome sequence analysis of multidrug-resistant Acinetobacter baumannii. J Bacteriol 190:8053. http://dx.doi.org/10.1128/JB.00834-08.
85. Jacobs AC, Thompson MG, Black CC, Kessler JL, Clark LP, McQueary CN, Gancz HY, Corey BW, Moon JK, Si Y, Owen MT, Hallock JD, Kwak YI, Summers A, Li CZ, Rasko DA, Penwell WF, Honnold CL, Wise MC, Waterman PE, Lesho EP, Stewart RL, Actis LA, Palys TJ, Craft DW, Zurawski DV. 2014. AB5075, a highly virulent isolate of Acinetobacter baumannii, as a model strain for the evaluation of pathogenesis and antimicrobial treatments. mBio 5:e01076-14. http://dx.doi.org/10.1128/mBio.01076-14.